- Home
- AMRN vs MYN Comparison
AMRN vs MYN Comparison
Compare AMRN & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- MYN
- Stock Information
- Founded
- AMRN 1989
- MYN 1992
- Country
- AMRN Ireland
- MYN United States
- Employees
- AMRN N/A
- MYN N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- MYN Finance Companies
- Sector
- AMRN Health Care
- MYN Finance
- Exchange
- AMRN Nasdaq
- MYN Nasdaq
- Market Cap
- AMRN 317.1M
- MYN 358.2M
- IPO Year
- AMRN 1993
- MYN N/A
- Fundamental
- Price
- AMRN $14.95
- MYN $9.88
- Analyst Decision
- AMRN Strong Sell
- MYN
- Analyst Count
- AMRN 1
- MYN 0
- Target Price
- AMRN $12.00
- MYN N/A
- AVG Volume (30 Days)
- AMRN 49.5K
- MYN 86.0K
- Earning Date
- AMRN 10-29-2025
- MYN 01-01-0001
- Dividend Yield
- AMRN N/A
- MYN 4.12%
- EPS Growth
- AMRN N/A
- MYN N/A
- EPS
- AMRN N/A
- MYN N/A
- Revenue
- AMRN $219,361,000.00
- MYN N/A
- Revenue This Year
- AMRN N/A
- MYN N/A
- Revenue Next Year
- AMRN N/A
- MYN N/A
- P/E Ratio
- AMRN N/A
- MYN N/A
- Revenue Growth
- AMRN N/A
- MYN N/A
- 52 Week Low
- AMRN $7.08
- MYN $8.47
- 52 Week High
- AMRN $17.49
- MYN $10.62
- Technical
- Relative Strength Index (RSI)
- AMRN 46.89
- MYN 73.92
- Support Level
- AMRN $14.54
- MYN $9.79
- Resistance Level
- AMRN $15.46
- MYN $9.94
- Average True Range (ATR)
- AMRN 0.47
- MYN 0.10
- MACD
- AMRN -0.04
- MYN 0.05
- Stochastic Oscillator
- AMRN 34.45
- MYN 90.67
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock
Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.